765 related articles for article (PubMed ID: 15217320)
1. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
[TBL] [Abstract][Full Text] [Related]
2. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
[TBL] [Abstract][Full Text] [Related]
3. Long lasting BCG protection against leprosy.
Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
[TBL] [Abstract][Full Text] [Related]
4. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial.
Cunha SS; Alexander N; Barreto ML; Pereira ES; Dourado I; Maroja Mde F; Ichihara Y; Brito S; Pereira S; Rodrigues LC
PLoS Negl Trop Dis; 2008 Feb; 2(2):e167. PubMed ID: 18270542
[TBL] [Abstract][Full Text] [Related]
5. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
Velema JP; Ogbeiwi OI
Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil.
Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274
[TBL] [Abstract][Full Text] [Related]
7. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
9. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
[TBL] [Abstract][Full Text] [Related]
10. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
12. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age.
Barreto ML; Rodrigues LC; Cunha SS; Pereira S; Hijjar MA; Ichihara MY; de Brito SC; Dourado I
Control Clin Trials; 2002 Oct; 23(5):540-53. PubMed ID: 12392870
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of BCG vaccination among leprosy contacts: a cohort study.
Düppre NC; Camacho LA; da Cunha SS; Struchiner CJ; Sales AM; Nery JA; Sarno EN
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):631-8. PubMed ID: 18514242
[TBL] [Abstract][Full Text] [Related]
14. [Where do we stand with BCG vaccination programme in Japan?].
Mori T
Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
16. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M
Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384
[TBL] [Abstract][Full Text] [Related]
17. Research on BCG vaccination.
ten Dam HG
Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
[TBL] [Abstract][Full Text] [Related]
18. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
[TBL] [Abstract][Full Text] [Related]
19. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma.
Bechelli LM; Lwin K; Gallego Garbajosa P; Mg-Mg-Gyi ; Uemura K; Sundaresan T; Tamondong C; Matejka M; Sansarricq H; Walter J
Bull World Health Organ; 1974; 51(1):93-9. PubMed ID: 4281729
[TBL] [Abstract][Full Text] [Related]
20. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
